Case number 1:20-cv-01104
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 13, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Feb 3, 2021 | 23 | Scheduling Order (22) Docket Text: SCHEDULING & CONSOLIDATION ORDER: 18-651-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN 18-651-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 8/20/2021. Joint Claim Construction Brief due by 7/23/2021. A Markman Hearing is set for 8/25/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 2/16/2022. A Final Pretrial Conference is set for 3/9/2022 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 3/28/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/3/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Feb 3, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-651-CFC ONLY. (nmf) |
| Feb 3, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(cak) |
| Jan 29, 2021 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendant's Rule 26 Initial Disclosures 2. Defendant's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 29, 2021 | 22 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 29, 2021 | 21 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (205 in 1:18-cv-00651-CFC, 21 in 1:20-cv-01334-CFC, 18 in 1:20-cv-01104-CFC, 20 in 1:20-cv-01333-CFC) Stipulation filed by Vanda Pharmaceuticals Inc.. Ordered by Judge Colm F. Connolly on 1/29/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 29, 2021 | 20 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 27, 2021 | 18 | Stipulation (5) Docket Text: Joint STIPULATION and [Proposed] Order Regarding Amendment of Expert Report by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 27, 2021 | 17 | Proposed Order (22) Docket Text: Joint PROPOSED ORDER Joint [Proposed] Scheduling Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 25, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the stipulation to extend time has been replaced to reflect the correct year. The text of the stipulation as well as the "so ordered" entry have also been updated to change the year to 2021 in the text. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (18 in 1:20-cv-01333-CFC, 19 in 1:20-cv-01334-CFC, 203 in 1:18-cv-00651-CFC, 16 in 1:20-cv-01104-CFC) STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 filed by Vanda Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 1/25/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) Modified on 1/25/2021 (nmf). |
| Jan 22, 2021 | 16 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 1/25/2021 (nmf). (Main Document 16 replaced on 1/25/2021) (nmf, ). |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01333-CFC, 202 in 1:18-cv-00651-CFC, 15 in 1:20-cv-01104-CFC, 18 in 1:20-cv-01334-CFC) Stipulation filed by Teva Pharmaceuticals USA, Inc.. Ordered by Judge Colm F. Connolly on 1/19/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 15, 2021 | 15 | Stipulation (3) Docket Text: STIPULATION (and proposed order) to extend time to submit proposed revised scheduling order by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jan 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney J.C. Rozendaal for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jan 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sasha S. Rao for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jan 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William H. Milliken for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jan 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Deirdre M. Wells for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jan 8, 2021 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 1/8/2021. (Court Reporter V. Gunning.) Counsel to confer and submit a revised proposed scheduling order to the Court on or before January 15, 2021. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Deirdre M. Wells, William H. Milliken, and Sasha S. Rao filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 1/5/2021. (fms) |
| Jan 5, 2021 | 14 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J.C. Rozendaal, Deirdre M. Wells, William H. Milliken, and Sasha S. Rao - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Dec 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (14 in 1:20-cv-01333-CFC, 13 in 1:20-cv-01104-CFC, 16 in 1:20-cv-01334-CFC) Letter, Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 1/8/2021 at 01:00 PM before Judge Colm F. Connolly. Counsel for Plaintiff shall coordinate the call and email the dial-in information to chambers.) Ordered by Judge Colm F. Connolly on 12/22/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Dec 21, 2020 | 13 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding joint proposed Scheduling Order. (Attachments: # (1) Text of Proposed Order [Proposed] Scheduling Order)(Fahnestock, Derek) |
| Dec 21, 2020 | 13 | Text of Proposed Order [Proposed] Scheduling Order (20) |
| Nov 19, 2020 | 12 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before December 21, 2020, counsel for plaintiff shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted or alternatively, submit a joint proposed scheduling order to the Court. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/21/2020.) Signed by Judge Colm F. Connolly on 11/19/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Oct 22, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(kmd) |
| Oct 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (7 in 1:20-cv-01334-CFC, 10 in 1:20-cv-01104-CFC, 9 in 1:20-cv-01333-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein and Jennifer Rae Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/13/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Oct 9, 2020 | 11 | Answer to Counterclaim (8) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 8, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein and Jennifer Rae Deneault - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Sep 18, 2020 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Sep 18, 2020 | 8 | Answer to Complaint (19) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Vanda Pharmaceuticals Inc. by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Aug 31, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. Teva Pharmaceuticals USA, Inc. served on 8/28/2020, answer due 9/18/2020. (Fahnestock, Derek) |
| Aug 26, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Aug 24, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Aug 21, 2020 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3146500.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(mal) |
| Aug 21, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (mal) |
| Aug 21, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,610,510 ;10,610,511. (mal) |
| Aug 21, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/10/2020. Date of Expiration of Patent: see attachment. Thirty Month Stay Deadline: N/A (mal) |
| Aug 21, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Aug 21, 2020 | 1 | Civil Cover Sheet (1) |
| Aug 21, 2020 | 1 | Exhibit A-B (42) |
| Aug 21, 2020 | 1 | Complaint* (1) |
